Evotec Statistics
NASDAQ: EVOHealth CareBiotechnology: Pharmaceutical PreparationsUSD
1.32-0.13 (-8.97%)
At close: Nov 20, 4:00 PM ET · Delayed 15 min
Evotec by the numbers
Evotec has a market capitalization of $469.1 million based on 355.39M shares outstanding. With trailing EPS of $-0.59, Evotec is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 15.5% below its 50-day average and 44.3% below its 200-day average.
Average daily trading volume is 109.16K shares, or about $144,086 in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
EVO valuation vs. peer median
| Metric | EVO | Peer median | Difference |
|---|---|---|---|
| Market cap | $469.11M | $461.00M | +2% |
| Avg. volume | 109.16K | 308.58K | -65% |
Peer median across 8 companies: MNPR, RZLT, BLSM, GYRE, NGNE, ASMB, STTK, HELP.
Valuation
- Market cap
- $469.11M
- EPS (TTM)
- $-0.59
- Shares outstanding
- 355.39M
Price and trading
- Previous close
- 1.45
- Open
- 1.38
- Day range
- 1.32 – 1.38
- 52-week range
- 1.32 – 3.87
- 52-week change
- -55.56%
- Beta
- —
- Volume
- 77.59K
- Average volume
- 109.16K
Dividends and events
- Annual dividend
- None
- Next earnings date
- Nov 5, 2026
Additional statistics
- Market Cap
- 469.11M
- Forward Pe
- -6.95
- Eps
- -0.59
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 3.87
- Week52 Low
- 1.32
- Avg Volume
- 109.16K
- Shares Outstanding
- 355.39M
- Ma50
- 1.56
- Ma200
- 2.37
- Earnings Date
- Nov 5, 2026
- Pct From52w High
- -65.89%
- Pct From52w Low
- 0.00%